Bio-Reference Laboratories News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

23.12.23	Nukkleus Inc. Closes Merger with Brilliant Acquisition Corporation (PR Newswire)
22.03.22	Brilliant Acquisition Corporation Announces Extension of Completion Window to July 23, 2022 (PR Newswire)
03.03.22	SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates LAWS, BRLI, ARIZ, DNAA, DNAC (PR Newswire)
23.02.22	SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates TEN, BRLI, FTSI, MIME (PR Newswire)
22.11.16	Lionel's Mega Tracks Races to the Top of Holiday Toy Lists (PR Newswire)
04.06.15	Opko Health To Buy Bio-Reference Laboratories For $1.47 Bln (RTTNews)
04.06.15	OPKO Health, Inc. To Acquire Bio-Reference Laboratories - Quick Facts (RTTNews)
14.04.15	BioReference Laboratories knüpft Partnerschaften mit Organisationen an, um die Innovation im medizinischen Bereich zu beschleunigen (GlobeNewswire)
14.04.15	BioReference Lab Partners With Two Organizations Accelerating Medical Innovation (RTTNews)
14.04.15	BioReference Laboratories Partners With Organizations Accelerating Medical Innovation (GlobeNewswire)
26.02.15	AMGN Study Meets Goal, BRLI Hits New High, DPRX On Watch, GMED Opens Wallet (RTTNews)
18.12.14	Bio-Reference Laboratories Q4 Profit Rises - Quick Facts (RTTNews)
05.06.14	Bio-Reference Laboratories Q2 Profit Tops View (RTTNews)
19.12.13	Bio-Reference Laboratories Profit Falls On Costs (RTTNews)
27.11.13	BioReference Labs Sees Q4 EPS To Be About $0.40 - Quick Facts (RTTNews)
23.10.13	EPZM, MDVN On Watch, MYGN In Legal Spat With BRLI, ONVO's 3D Story Gets Better (RTTNews)
22.10.13	Myriad Genetics Files Suit Against BioReference Labs. - Quick Facts (RTTNews)
29.08.13	Bio-Reference Labs Q3 Profit Rises - Quick Facts (RTTNews)
26.08.13	GeneDx Introduces Advanced Genetic Test Panels for Inherited Cancer Including Breast and Colon Cancer (PR Newswire)
26.08.13	GeneDx Introduces Advanced Genetic Test Panels for Inherited Cancer Including Breast and Colon Cancer (PR Newswire)
22.08.13	Incyte Excites, ADMP Entitled To Patent, BSX Gets Two Thumbs Up, ORMP On Watch (RTTNews)
21.08.13	BioReference Labs To Acquire Edge BioSystems' Service Business (RTTNews)
08.08.13	Bio-Reference Laboratories and Coastal VIM Clinic Partner to Provide Free Clinical Tests to Patients (PR Newswire)
05.08.13	Strategic Initiatives, Executive Transitions, and Strengthened Portfolios to Increase Shareholder Value - Research Report on Trius, HCA, Alere, UHS, and Bio-Reference (PR Newswire)
14.09.09	BioReference Laboratories, Inc to Speak at the UBS Global Life Sciences Conference (Businesswire)
19.09.08	BioReference Laboratories, Inc to Speak at the UBS Global Life Sciences Conference (Businesswire)
06.02.08	BioReference Laboratories, Inc. to Speak at the UBS Global Healthcare Services Conference (Businesswire)
02.10.07	BioReference Laboratories, Inc. to Speak at the William Blair Small-Cap Growth Stock Conference (Businesswire)
21.09.06	Bio-Reference Laboratories, Inc. to Speak at the UBS Global Life Sciences Conference (Businesswire)
11.07.06	BioReference Laboratories Announces Its Inclusion in the New NASDAQ Global Select Market (Businesswire)
03.03.05	Bio-Reference Laboratories, Inc. Records 27% Increase in Q1 Net Revenu (Businesswire)
24.02.05	Bio-Reference Laboratories, Inc. Announces Earnings Date for the First (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Holcim	91.22	1.56 %	K V
Sonova Hldg	319.70	1.56 %	K V
Lonza Grp	591.00	1.34 %	K V
Sika	231.50	1.27 %	K V
CieFinRichemont	171.70	0.94 %	K V
Swiss Re	138.05	-0.40 %	K V
Zurich Insur Gr	537.20	-0.52 %	K V
Kuehne+Nagel Int	204.60	-0.97 %	K V
Part Grp Hldg	1’389.50	-1.03 %	K V
Givaudan	3’818.00	-3.12 %	K V

Nachrichten zu Bio-Reference Laboratories Inc Stock Settlement

Aktien Top/Flop

Meistgelesene Nachrichten